Expert Interview
Delving into the Phase 2 Study of ponsegromab from Pfizer in Patients with Cancer Cachexia
Ticker(s): PFEInstitution: South Nassau Oncology
- Senior Partner of South Nassau Oncology, Professor of Medicine at the Mount Sinai Hospital and Former Director of the Cancer Program at the Mount Sinai Hospital
- Manages 25+ NSCLC and 80 patients with AML
- Clinical focus on hematological malignancies, including multiple myeloma, non-Hodgkin lymphoma and leukemias; as well as cancers of the lung, colon and breast.
How many patients with cancer cachexia do you manage in a month?
Added By: emily_adminIf approved, where do you see ponsegromab fitting into the current treatment space for cancer cachexia?
Added By: emily_adminWhat is your opinion on the data to date for ponsegromab?
Added By: emily_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
